Meridian Investment Counsel Inc. Has $1.14 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Meridian Investment Counsel Inc. lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 12,707 shares of the exchange traded fund’s stock after selling 1,070 shares during the period. Meridian Investment Counsel Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,144,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of XBI. Mirae Asset Securities USA Inc. lifted its holdings in SPDR S&P Biotech ETF by 66.7% in the fourth quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after buying an additional 600,000 shares during the period. Proficio Capital Partners LLC lifted its stake in shares of SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after purchasing an additional 911,686 shares during the period. Raymond James Financial Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $55,529,000. Clearbridge Investments LLC grew its stake in SPDR S&P Biotech ETF by 20.5% during the fourth quarter. Clearbridge Investments LLC now owns 571,664 shares of the exchange traded fund’s stock worth $51,484,000 after purchasing an additional 97,401 shares during the period. Finally, Whittier Trust Co. increased its holdings in SPDR S&P Biotech ETF by 3.1% in the fourth quarter. Whittier Trust Co. now owns 320,740 shares of the exchange traded fund’s stock worth $28,885,000 after purchasing an additional 9,713 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $84.40 on Monday. The firm has a market cap of $5.47 billion, a PE ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The business’s 50 day moving average price is $89.40 and its two-hundred day moving average price is $93.91.

SPDR S&P Biotech ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were paid a $0.0053 dividend. The ex-dividend date was Monday, March 24th.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.